Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$127.29 USD
+1.10 (0.87%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $127.29 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Abbott Laboratories has a PEG ratio of 2.51 compared to the Medical - Products industry's PEG ratio of 2.14.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ABT 127.29 +1.10(0.87%)
Will ABT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABT
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Wells Fargo, Abbott Laboratories, American Express, TSS and Maui Land & Pineapple
Top Stock Reports for Wells Fargo, Abbott & American Express
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Other News for ABT
IXJ: A Bet On Global Healthcare Recovery
This New ETF Brings Out The Best In S&P 500 Without The Tech Overload
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
BME: The Resilient Income Investment Of The Healthcare Industry
Best Dividend Aristocrats For August 2025